By simultaneously aiming at GLP-1, GIP, and glucagon receptors, these drugs, such as retatrutide, deliver significantly greater efficacy than current therapies, expanding the addressable patient base
Tirzepatide treatment was not associated with excess cardiovascular risk (54, 74)
Yes, and they often are taken together
If we understand the root causes of our weight issues and address them, GLP therapies may be a liberating tool to get on track with your health
Patients whose coverage changes mid-treatment face difficult decisions about continuing at higher out-of-pocket cost, switching to compounded versions, or stopping prematurely
RETATRUTIDE: THE NEXT GENERATION OF WEIGHT LOSS Why This Triple-Action Compound Is Dominating Clinical Trials The Weight Loss Revolution Is Here Youve probably heard of Ozempic or Mounjaro the so-called miracle weight-loss shots taking over social media